In this Q&A, Jenna DiRito, PhD, COO and co-founder of Revalia Bio, discusses how earlier, human-relevant data is reshaping go/no-go decision-making in drug development and what a truly front-loaded workflow looks like in practice.
Jenna DiRito, PhD
Advertisement
COO and Co-Founder of Revalia Bio
Articles by Jenna DiRito, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Seeks Public Input on Early-Phase Clinical Trial Design for Ibogaine
2
FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review
3
Mixed Outsourcing Models Are Spreading. Is Sponsor Oversight Keeping Up?
4
Beyond the Molecule: Why Radiopharmaceutical Trials Require a New Operating Model
5